JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Ultragenyx Pharmaceutical (RARE) to Offer $125M in Common Stock
-
JMP Securities Downgrades Broadcom (BRCM) to Market Perform
-
JMP Securities Downgrades Align Technology (ALGN) to Market Perform
-
Notable Analyst Rating Changes 1/29: (CYOU) (BR) (RKT) Upgraded; (CAVM) (XEC) (MSFT) Downgraded
-
Flex Pharm (FLKS) IPO Opens Up 19%
-
Neovasc (NVCN) Increases Size of Stock Offering Due to Interest, 10.5M Prices at $7.19/Share
-
JMP Securities Downgrades Cavium Networks (CAVM) to Market Perform
-
Vitae Pharmaceuticals Announces Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Follow-on Public Offering of Common Stock
-
JMP Securities Downgrades RE/MAX Holdings (RMAX) to Market Underperform
-
JMP Securities Downgrades Qualys (QLYS) to Market Perform
-
Vitae Pharmaceuticals (VTAE) Prices 3M Common Follow-On at $11.90/Share
-
Vitae Pharmaceuticals Announces Pricing of Follow-on Public Offering of Common Stock
-
Zafgen (ZFGN) Prices Larger 3.94M Common Offering at $35/Share
-
Keryx Biopharma (KERX) Prices 9.17M Common Offering at $12/Share
-
Keryx Biopharmaceuticals, Inc. Announces Pricing of $110 Million Public Offering of Common Stock
-
JMP Securities Downgrades Forestar Group (FOR) to Market Perform
-
JMP Securities Starts Capitala Finance (CPTA) at Market Outperform
-
Alnylam Pharma (ALNY) Prices 4.74M Common Offering at $95/Share
-
Zafgen (ZFGN) to Offer 2.84M Common Shares
-
Notable Analyst Rating Changes 1/20: (BAC) (MU) (EXC) Upgraded; (ADM) (INTC) (YNDX) Downgraded
-
JMP Securities Downgrades M/I Homes (MHO) to Market Perform
-
JMP Securities Downgrades Hovnanian Enterprises (HOV) to Market Underperform
-
JMP Securities Downgrades Taylor Morrison Home (TMHC) to Market Perform
-
Vitae Pharmaceuticals Launches Proposed Follow-on Public Offering of Common Stock
-
JMP Securities Downgrades Intel (INTC) to Market Underperform
-
Patriot National (PN) IPO Opens for Lower
-
JMP Securities Downgrades Sabra Healthcare REIT Inc. (SBRA) to Market Underperform
-
JMP Securities Downgrades National Health Investors (NHI) to Market Perform
-
Notable Analyst Rating Changes 1/12: (FTR) (CHK) (AA) Upgraded; (ADT) (WNR) (DHI) Downgraded
-
JMP Securities Downgrades Aruba Networks (ARUN) to Market Perform
-
JMP Securities Downgrades Select Medical Holdings (SEM) to Market Underperform
-
JMP Securities Downgrades Morgan Stanley (MS) to Market Perform
-
JMP Securities Downgrades Goldman Sachs (GS) to Market Perform
-
PlacementTracker Publishes 2014 PIPE Market League Tables
-
Karyopharm Therapeutics (KPTI) Prices 3M Common Offering at $33/Share
-
Sutherland Asset Management (SLD) Launches 8.06M Common IPO; Sees Pricing at $15 - $16/Share
-
JMP Securities Starts New Relic (NEWR) at Market Outperform
-
Karyopharm Therapeutics (KPTI) Reports 3M Share Stock Offering
-
Karyopharm Therapeutics (KPTI) Announces 2.95M Common Offering
-
Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock
-
HTG Molecular Diagnostics (HTGM) Files $60M IPO
-
Nexvet (NVET) Files $60M IPO
-
Notable Analyst Rating Changes 12/30: (SWN) Upgraded; (ARR) (BBT) (PG) Downgraded
-
JMP Securities Starts Pernix Therapeutics (PTX) at Market Outperform
-
Carbylan Therapeutics (CBYL) Files $86.25M IPO
-
JMP Securities Starts Halyard Health (HYH) at Market Outperform
-
JMP Securities Starts Intra-Cellular Therapies (ITCI) at Market Outperform
-
JMP Securities Starts Hortonworks (HDP) at Market Outperform
-
JMP Securities Starts Sotherly Hotels (SOHO) at Market Outperform
-
JMP Securities Starts Zendesk (ZEN) at Market Outperform

